Wednesday, May 26, 2010

New Stanek column, “On the path to over-the-counter abortions”


On June 17, the FDA's Advisory Committee for Reproductive Health will hold a public hearing to begin the approval process of a new abortion pill, Ulipristal acetate, to be marketed by the brand names ella® or ellaOne®.

ellaOne can be taken up to 5 days after unprotected sex, as opposed to emergency contraception, which can be taken up to 3 days after unprotected sex.

ellaOne has been marketed in the United Kingdom since September 2009 as an emergency contraceptive, but it does not chemically work the same in a woman's body as an EC.

In fact, ellaOne works the same as mifepristone, or RU486, also known as the abortion pill, which can be taken up to 49 days after the first day of a woman's last period....

A "fact sheet" by the Reproductive Health Technologies Project, which is pushing FDA approval of ellaOne, confirms "mifepristone [RU486] and ulipristal acetate [ellaOne] are both selective progesterone modulators."...

ellaOne is an abortion pill. Backers want it considered an EC to make it available first by prescription and then over-the-counter, as was the EC.

If the FDA approves ellaOne as an EC, the day draws closer when abortion proponents push to make RU486 available first by prescription and then over-the-counter....

Continue reading my column today, "On the path to over-the-counter abortions," at
Click here for live video

Send Us Your Pro-Life News

Send us your photos, articles, videos and audio, or sign up to become a roving reporter.


  • Join us at
  • Volunteer for Action
  • Take Action Calendar
  • News Links
  • .(JavaScript must be enabled to view this email address)

    Advanced Search

    Multimedia Pro Life News - Multimedia Pro-Life news - Multimedia ProLife News - Multimedia ProLifeNews - - ProLife News - ProLifeNews